2-Year U.S. Treasury Note Continuous Contract $102.871 0.027 0.03% 5-Year U.S. Treasury Note Continuous Contract $106.578 0.141 0.13% 10-Year U.S. Treasury Note Continuous Contract $109.188 0.234 ...

Within 1 year, a single institution saw four patients with MSSA infections who developed AKI that was most likely secondary to nafcillin-associated AIN. Records from the institution show that ...

2-Year U.S. Treasury Note Continuous Contract $102.918 0.031 0.03% 5-Year U.S. Treasury Note Continuous Contract $106.602 0.102 0.10% 10-Year U.S. Treasury Note Continuous Contract $109.203 0.172 ...

Expert Rev Anti Infect Ther. 2009;7(8):967-980. Nafcillin is considered the intravenous treatment of choice for MSSA; however, many other intravenous agents such as cephalosporins, β-lactams and ...